ERVEBO sol inj 10 vial 1 ml

7680683580018 CH-68358 J07BX02 08.08.
ERVEBO sol inj 10 vial 1 ml
ERVEBO sol inj 10 vial 1 ml
ERVEBO sol inj 10 vial 1 ml
1 / 3
google

Details

Product number
6835801
CPT
-
Packaging group
10
Unit
Durchstechflasche(n)
Composition
rVSVdeltaG-ZEBOV-GP vivus attenuatum >7.2 Mio U., trometamolum, albuminum humanum, aqua ad iniectabile, q.s. ad solutionem pro 1 ml.

Articles (1)

Ervebo, Injektionslösung
Injektionslösung
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
29/08/2024
Professional SmPC
Français
29/08/2024
Professional SmPC
Italien
29/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
68358
Drug name
Ervebo, Injektionslösung
Galenic form
LSIN
ATC Code
J07BX02
Authorization status
Z
Dispensation category
B
First authorization
10/11/2021
Authorization expiration date
09/11/2026
IT number
08.08.
Domain
Human medicine
Field of application
Ervebo ist indiziert für die aktive Immunisierung von Personen ab 1 Jahr zum Schutz vor der Ebola-Viruskrankheit (EVD [Ebola Virus Disease]), die durch das Zaire-Ebola-Virus verursacht wird.

Packaging details

Description (FR)
ERVEBO sol perf >7.2 Mio U. 10 pce
Description (DE)
ERVEBO Inf Lös >7.2 Mio U. 10 Stk
Market launch
10/11/2021
Narcotic (BTM)
No

Application methods

IMU